DGAP-DD: STRATEC Biomedical AG english

Notification concerning transactions by persons performing managerial
responsibilities pursuant to section 15a of the WpHG

Directors' Dealings notification transmitted by DGAP - a company of
EquityStory AG.
The person with duty of notification is solely responsible for the content
of this announcement.
---------------------------------------------------------------------------

Details of the person subject to the disclosure requirement
Last name: Wolfinger
First name: Marcus

Position: Member of a managing body

Information about the transaction with duty of notification

Description of the financial instrument: STRATEC Biomedical AG / Ordinary
Share
ISIN/WKN of the financial instrument: DE0007289001
Type of transaction: Sale
Date: 24.05.2012
Price: 29.9878
Currency: EUR
No. of items: 4500
Total amount traded: 134945.10
Place: außerbörslich / OTC

Explanation for publication:

Cashless exercise (exercising of stock options incl. block sale of stocks
to investor via bank; strike price for underlying stock options: Euro 9.23
per stock option). The shares thereby sold result from stock options
granted as a component of compensation.

Information about the company with duty of publication

Issuer: STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Deutschland
ISIN: DE0007289001
WKN: 728900


End of Directors' Dealings Notification 
(c) DGAP 25.05.2012

DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

ID 15303